Biodexa Pharmaceuticals (BDRX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Biodexa Pharmaceuticals

    NASDAQ: BDRX · Real-Time Price · USD
    5.32
    -0.33 (-5.84%)
    At close: Sep 08, 2025, 3:59 PM
    5.16
    -3.01%
    After-hours: Sep 08, 2025, 07:32 PM EDT

    Biodexa Pharmaceuticals Balance Sheet Statement

    Financials in GBP. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 1.67M 5.97M 2.84M 10.06M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a -837K -1.15M
    Receivables
    		 715K 704K 329K 33K
    Inventory
    		 n/a -704K n/a n/a
    Other Current Assets
    		 n/a 704K n/a n/a
    Total Current Assets
    		 8.81M 7.03M 4.69M 11.76M
    Property-Plant & Equipment
    		 324K 571K 831K 1.15M
    Goodwill & Intangibles
    		 5.65M 2.94M 6K n/a
    Total Long-Term Assets
    		 5.97M 3.51M 837K 1.15M
    Total Assets
    		 14.78M 10.54M 5.53M 12.91M
    Account Payables
    		 707K 314K 339K 485K
    Deferred Revenue
    		 1.47M n/a 197K n/a
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 921K 4.23M 583K 664K
    Total Current Liabilities
    		 5.03M 5.57M 1.9M 1.84M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 1.31M n/a n/a -469
    Total Long-Term Liabilities
    		 1.42M 295K 463K 619.53K
    Total Liabilities
    		 6.46M 5.86M 2.36M 2.46M
    Total Debt
    		 727K 464K 624K 766K
    Common Stock
    		 6.69M 1.19M 1.11M 98.47K
    Retained Earnings
    		 -150.42M -144.77M -135.34M -127.8M
    Comprehensive Income
    		 53M 61.52M 53M 53M
    Shareholders Equity
    		 8.32M 4.68M 3.16M 10.45M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist